Millbrook Healthcare has been acquired by Cairngorm Capital Partners LLP
The private shareholders of Millbrook Healthcare have sold the company to Cairngorm Capital Partners LLP.
Millbrook is a well-established nationwide provider of equipment, assessment and home-based services to help people live more independently, at home, for longer. The company supports individuals, along the care pathway through the provision of aids, ranging from walkers and frames through to bespoke wheelchairs and specialist active pressure care mattresses. Headquartered in Southampton, Millbrook has 28 depots across the UK, employs 1,000 people and offers a fully integrated service to public authorities.
Cairngorm Capital provides equity capital, strategic advice and management expertise to ambitious companies. In partnership with the long-established management team, it is keen to take advantage of the expected expansion of community care services in the UK and continue to deliver an industry-leading level of service to its key stakeholders.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction. The team worked with the directors and shareholders of Millbrook to deliver a successful sale to a partner with the appropriate strategic and operating experience to take the business through its next phase of growth.
Colin Croll
Chairman, Millbrook Healthcare
Talk to the deal team
Related deals
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn more